
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
caspase-8 CRISPR/Cas9 KO Plasmid (h) | sc-400147 | 20 µg | $397.00 | |||
caspase-8 HDR Plasmid (h) | sc-400147-HDR | 20 µg | $445.00 |
CASP8 encodes caspase-8, an initiator cysteine protease that couples extracellular death receptor signaling to proteolytic cascades controlling apoptosis. Upon activation at the death-inducing signaling complex downstream of FAS, TNFRSF, and TRAIL receptors, caspase-8 triggers effector caspases and intersects with mitochondrial apoptosis via BID cleavage. Beyond cell death, caspase-8 regulates inflammatory signaling and restrains RIPK1/RIPK3-dependent necroptosis, shaping immune homeostasis and tissue integrity. Dysregulation of CASP8 has been associated with altered apoptosis competence, immune dysregulation, and oncogenic processes linked to evasion of cell death.
caspase-8 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CASP8 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the CASP8 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, caspase-8 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined CASP8 target site.
When co-transfected with caspase-8 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the CASP8 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.